Wednesday, August 13, 2014
(Undated) -- Shares in the Canadian pharmaceutical company Tekmira are soaring after the FDA eased off on a hold it had placed on an Ebola treatment currently under development. The FDA move will allow for the potential use of the new treatment in people already infected with Ebola. That news sent shares surging north late last week, with a gain of more than 45 percent on Friday. So far today, Tekmira is up another 20 percent.